Carl Zeiss Meditec AG
XETRA:AFX
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
54.65
121.95
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Carl Zeiss Meditec AG
Gross Margin
Carl Zeiss Meditec AG
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | DE |
| Market Cap | 5B EUR |
| Gross Margin |
55%
|
| Country | US |
| Market Cap | 204.9B USD |
| Gross Margin |
56%
|
| Country | US |
| Market Cap | 195.2B USD |
| Gross Margin |
67%
|
| Country | US |
| Market Cap | 146.7B USD |
| Gross Margin |
64%
|
| Country | US |
| Market Cap | 132.6B USD |
| Gross Margin |
69%
|
| Country | IE |
| Market Cap | 110.6B USD |
| Gross Margin |
66%
|
| Country | US |
| Market Cap | 64.7B USD |
| Gross Margin |
45%
|
| Country | DE |
| Market Cap | 55.6B EUR |
| Gross Margin |
38%
|
| Country | CN |
| Market Cap | 319.2B CNY |
| Gross Margin |
65%
|
| Country | US |
| Market Cap | 41.6B USD |
| Gross Margin |
79%
|
| Country | US |
| Market Cap | 37.7B USD |
| Gross Margin |
41%
|
Carl Zeiss Meditec AG
Glance View
Carl Zeiss Meditec AG engages in the development, manufacture and marketing of medical devices. The company is headquartered in Jena, Thueringen and currently employs 3,531 full-time employees. The company went IPO on 2000-03-20. The company offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The firm operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The firm has various production sites in Europe, the United States and Asia.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Carl Zeiss Meditec AG's most recent financial statements, the company has Gross Margin of 55.1%.
You don't have any saved screeners yet
